A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: AGORACOM Small Cap 60: Clinical study of Valeo Immune Booster Yields Encouraging Results, May Help Reduce COVID-19 Associated Symptoms
Reply New Message
Back To Forum List View

AGORACOM Small Cap 60: Clinical study of Valeo Immune Booster Yields Encouraging Results, May Help Reduce COVID-19 Associated Symptoms

posted on Jan 18, 2022 10:58AM
Log in to use the IP Check tool [?]

Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply